Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

Clinical trial NCT01798056 · COMPLETED

Trial details

NCT number: NCT01798056
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Herpes Zoster Herpes Zoster Vaccine

Start date: 2013-03-06
Primary completion: 2015-06-18
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.